In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 90766-97-5, name is 5-Bromo-6-phenylpyridazin-3(2H)-one, introducing its new discovery. Recommanded Product: 5-Bromo-6-phenylpyridazin-3(2H)-one
PYRIDAZINONE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
Compounds of formula (I) described herein inhibit phosphoinositide 3-kinases (PI3K) and useful for the treatment of disorders associated with PI3K enzymes.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 90766-97-5, and how the biochemistry of the body works.Recommanded Product: 5-Bromo-6-phenylpyridazin-3(2H)-one
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N3119 – PubChem